Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Cancel Anytime
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

The National Microbiology Laboratory in Winnipeg on May 19, 2009.

JOHN WOODS/The Canadian Press

Scientists working at Canada’s highest-security infectious-disease laboratory have been collaborating with Chinese military researchers to study and conduct experiments on deadly pathogens.

Seven scientists in the special pathogens unit at the National Microbiology Laboratory (NML) in Winnipeg and Chinese military researchers have conducted experiments and co-authored six studies on infectious diseases such as Ebola, Lassa fever and Rift Valley fever. The publication dates of the studies range from early 2016 to early 2020.

The Globe and Mail has also learned that one of the Chinese researchers, Feihu Yan, from the People’s Liberation Army’s (PLA) Academy of Military Medical Sciences, worked for a period of time at the Winnipeg lab, a Level 4 facility equipped to handle some of the world’s deadliest diseases. This researcher is credited as a co-author on all six of the papers. However, on two of them, he is listed as being affiliated with both the Winnipeg lab and the military medical academy.

Story continues below advertisement

Alberta vows to curb university’s research ties to China

Two of the Winnipeg lab scientists, Xiangguo Qiu and her biologist husband, Keding Cheng, were fired in January of this year after the Canadian Security Intelligence Service, as The Globe reported last week, recommended that their security clearances be removed on national-security grounds. CSIS had also been concerned about the nature of information Dr. Qiu might have passed on to China’s Wuhan Institute of Virology.

Dr. Qiu, the former head of the Vaccine Development and Antiviral Therapies section at the Winnipeg lab’s Special Pathogens Program, co-authored five of the studies. Dr. Cheng participated in one study on Ebola.

Eric Morrissette, a spokesman for the Public Health Agency of Canada (PHAC), which oversees the Winnipeg lab, said the PLA researcher “did work with Dr. Qiu as indicated in the publications. However, the individual was not an employee of the National Microbiology Laboratory.”

Mr. Morrissette said all individuals working within NML undergo a security screening and must adhere to PHAC “security protocols, procedures and policies based on the level of access required.”

The Australian Strategic Policy Institute (ASPI), a think tank, has compiled a rating system to rank the risk that collaboration with Chinese universities might be “leveraged by the People’s Liberation Army or security agencies for surveillance, human-rights abuses or military purposes.”

ASPI rates the Academy of Military Medical Sciences as “very high risk” because it is the PLA’s premier institute for military science. The academy, which led the development of China’s coronavirus vaccine, oversees nine other research institutions in the country.

Andy Ellis, former CSIS assistant director of operations, said it is “madness” for the Public Health Agency of Canada to be co-operating with the PLA, which in recent years has ramped up its recruitment of scientists and invested heavily in medical research as part of its strategy to modernize its military.

Story continues below advertisement

“It is ill-advised. It is the top lab in Canada,” Mr. Ellis said in an interview. “It is just incredible naiveté on their part.”

Mr. Ellis said it is also astounding that PHAC allowed a PLA scientist into the Winnipeg lab that requires the highest-level security clearance to gain entry.

“We won’t let a Canadian in unless we have done a deep background check, but we let [someone] in that we don’t know anything about. It doesn’t make sense,” he added.

The Public Health Agency of Canada told The Globe in a statement that “collaborations with institutions outside of Canada is critical to advancing public-health research and science aimed at improving public health on a global scale.”

PHAC said no “new collaborations” on research projects have been initiated with China since the summer of 2019. All co-operation with the Wuhan Institute of Virology ended when Dr. Qiu, her husband and an unknown number of Dr. Qiu’s students had their security access revoked and were escorted from the Winnipeg lab on July 5, 2019.

“In scientific collaborations, when a principal investigator leaves an organization, it is normal that collaborations centred around that research wind down. In this instance, the principal investigator was Dr. Qiu,” PHAC said.

Story continues below advertisement

Dr. Qiu won a Governor-General’s award in 2018 for her work on Ebola.

In March, 2019, the Winnipeg lab had shipped Ebola and Henipah viruses to the Wuhan institute. PHAC later described that as an effort by Canada to “foster global collaboration.” E-mails released under Access to Information legislation show that Dr. Qiu played an essential role in negotiating the shipments to the Wuhan facility.

PHAC maintains that the couple’s dismissal was unrelated to the transfer of the viruses. The Globe reported last week that CSIS became alarmed about the people Dr. Qiu was talking to in China and intellectual property that may have been handed over to Chinese authorities.

Attempts to reach Dr. Qiu and her husband, who live in Winnipeg, were unsuccessful.

PHAC said in a statement to The Globe that co-operation with China on “a few other scientific publications are still under development based on completed experiments,” which could take months or even years to publish.

The federal government has said little publicly about the reasons for Dr. Qiu’s and Dr. Cheng’s dismissal although the RCMP were called in to investigate.

Story continues below advertisement

James Giordano, a professor in the departments of neurology and biochemistry at Georgetown University and a senior fellow in biowarfare and biosecurity at the U.S. Naval War College, said he assumes research conducted by any academic working in China is available for use by Beijing for military or defence purposes.

He said China is interested in developing new bioweapons, but also to furthering the capacity for what he calls “heroic rescue,” where Beijing is able to “ride in like a white knight” and offer other countries treatments or cures for diseases that threaten their population and increase its international influence.

Prof. Giordano said China is particularly interested in modifying pathogens to create a novel organism that is not listed – and therefore not regulated – in the international Biological and Toxin Weapons Convention.

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the authors of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies